About Opto.bio
Biological interfaces | Smaller. Softer. Wireless. Opto is a neurotechnology company developing breakthrough approaches to cancer treatment. Harnessing bioelectricity and tiny neural implants will change how we approach disease treatment.
- Founded
- 2022
- Employees
- 11 to 50
- Total funding
- $1.9M
Leadership
The top of Opto.bio's org chart, with how many people report into each leader.
EJ
Elise Jenkins
Co-founder, CTO
7 reports
MG
Maekele Gebrekidan
Principal Product Development Engineer
3 reports
JL
José Lepe
VP of Product & Engineering
2 reports
Jobs at Opto.bio
No open positions right now. Explore more companies on TheJobsMap.